Five-Year Follow Up of Thymoglobulin Versus ATGAM Induction in Adult Renal Transplantation-Reference-Cited by-同舟云学术

Five-Year Follow Up of Thymoglobulin Versus ATGAM Induction in Adult Renal Transplantation

Published:2004-07-15 Issue:1 Volume:78 Page:136-141
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Hardinger Karen L.,Schnitzler Mark A.,Miller Brent,Lowell Jeffrey A.,Shenoy Surendra,Koch Matthew J.,Enkvetchakul Decha,Ceriotti Connie,Brennan Daniel C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference10 articles.

1. A randomized, double-blinded, comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.;Brennan;Transplantation,1999

2. Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients.;Brennan;Transplantation,1997

3. Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy.;Brennan;J Am Soc Nephrol,1997

4. Short course induction immunosuppression with Thymoglobulin for renal transplant recipients.;Agha;Transplantation,2002

5. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.;Gaber;Transplantation,1998

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imlifidase in kidney transplantation;Clinical Kidney Journal;2024-02-09

2. Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines;Transplant International;2023-06-28

3. Induction Therapy in Pediatric Renal Transplant Recipients;Pediatric Solid Organ Transplantation;2023

4. Immunosuppression in Pediatric Kidney Transplantation;Pediatric Kidney Disease;2023

5. Considerations and controversies of pharmacologic management of the pediatric kidney transplant recipient;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-01